AU2002349754A1 - Novel 1,2,4-triazole compound - Google Patents

Novel 1,2,4-triazole compound

Info

Publication number
AU2002349754A1
AU2002349754A1 AU2002349754A AU2002349754A AU2002349754A1 AU 2002349754 A1 AU2002349754 A1 AU 2002349754A1 AU 2002349754 A AU2002349754 A AU 2002349754A AU 2002349754 A AU2002349754 A AU 2002349754A AU 2002349754 A1 AU2002349754 A1 AU 2002349754A1
Authority
AU
Australia
Prior art keywords
novel
triazole compound
triazole
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002349754A
Other versions
AU2002349754B2 (en
Inventor
Naoki Ashizawa
Tsutomu Inoue
Takashi Iwanaga
Soichi Kaneda
Koji Matsumoto
Hiroshi Nakamura
Takahiro Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuji Yakuhin Co Ltd
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Priority claimed from PCT/JP2002/012662 external-priority patent/WO2003064410A1/en
Publication of AU2002349754A1 publication Critical patent/AU2002349754A1/en
Application granted granted Critical
Publication of AU2002349754B2 publication Critical patent/AU2002349754B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002349754A 2002-01-28 2002-12-03 Novel 1,2,4-triazole compound Ceased AU2002349754B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-017825 2002-01-28
JP2002017825 2002-01-28
PCT/JP2002/012662 WO2003064410A1 (en) 2002-01-28 2002-12-03 Novel 1,2,4-triazole compound

Publications (2)

Publication Number Publication Date
AU2002349754A1 true AU2002349754A1 (en) 2003-09-18
AU2002349754B2 AU2002349754B2 (en) 2008-01-31

Family

ID=27653386

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002349754A Ceased AU2002349754B2 (en) 2002-01-28 2002-12-03 Novel 1,2,4-triazole compound

Country Status (22)

Country Link
US (1) US7074816B2 (en)
EP (1) EP1471065B1 (en)
JP (1) JP3600832B2 (en)
CN (1) CN1561340B (en)
AR (1) AR042602A1 (en)
AT (1) ATE387438T1 (en)
AU (1) AU2002349754B2 (en)
BR (1) BRPI0212775B8 (en)
CA (1) CA2462132C (en)
DE (1) DE60225341T2 (en)
DK (1) DK1471065T3 (en)
ES (1) ES2300486T3 (en)
HK (1) HK1067132A1 (en)
MX (1) MXPA04004037A (en)
NO (1) NO326941B1 (en)
NZ (1) NZ531673A (en)
PL (1) PL208260B1 (en)
PT (1) PT1471065E (en)
RU (1) RU2293733C2 (en)
TW (1) TWI257926B (en)
WO (1) WO2003064410A1 (en)
ZA (1) ZA200401777B (en)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2531912A1 (en) * 2003-07-24 2005-02-03 Fujiyakuhin Co., Ltd. Process for producing 1,2,4-triazole compound and intermediate therefor
US20060189811A1 (en) * 2004-07-23 2006-08-24 Fujiyakuhin Co., Ltd. Process for producing 1,2,4-triazole compound and intermediate therefor
CA2607953A1 (en) 2005-05-09 2006-11-16 Tap Pharmaceutical Products, Inc. Methods for treating nephrolithiasis
US20070167454A1 (en) * 2005-08-03 2007-07-19 Christopher Lademacher Methods for treating hypertension
US7947707B2 (en) 2005-10-07 2011-05-24 Kissei Pharmaceutical Co., Ltd. Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
KR20140043141A (en) * 2006-06-22 2014-04-08 닛뽕 케미파 가부시키가이샤 Agent for overcoming resistance to anti-cancer agent
JP5110536B2 (en) * 2006-07-19 2012-12-26 学校法人日本医科大学 Amyotrophic lateral sclerosis drug
KR20090103879A (en) * 2006-11-13 2009-10-01 다케다 파마슈티칼스 노쓰 어메리카, 인코포레이티드 Methods for preserving renal function using xanthine oxidoreductase inhibitors
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
MX2009007680A (en) * 2007-01-19 2011-08-03 Takeda Pharmaceuticals North America Inc Methods for preventing or reducing the number of gout flares using xanthine oxidoreductase inhibitors and anti-inflammatory agents.
JO2784B1 (en) * 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 1,3,5-trisubstitued triazole derivative
EP2217577B1 (en) * 2007-11-27 2014-08-06 Ardea Biosciences, Inc. Novel compounds and compositions and methods of use
EP2165705A1 (en) 2008-09-18 2010-03-24 Centre National de la Recherche Scientifique (CNRS) Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
KR101797936B1 (en) 2010-09-10 2017-11-15 다케다 파마슈티칼스 유에스에이, 인코포레이티드 Methods for concomitant treatment of theophylline and febuxostat
JP5862897B2 (en) * 2010-11-01 2016-02-16 株式会社三和化学研究所 Pharmaceuticals used for the prevention or treatment of renal dysfunction
PL2651915T3 (en) 2010-12-17 2016-11-30 Continuous arycyclic compound
US8541094B2 (en) 2011-03-01 2013-09-24 Empire Technology Development Llc Temperature controlled variable reflectivity coatings
RU2476428C1 (en) * 2011-09-01 2013-02-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Российский государственный технический университет (Новочеркасский политехнический институт)" Method of producing 5-amino-3-aminomethyl-1,2,4-triazole dihydrochloride
WO2013187496A1 (en) 2012-06-15 2013-12-19 田辺三菱製薬株式会社 Aromatic heterocyclic compound
IN2014DN10530A (en) * 2012-07-25 2015-08-21 Fujiyakuhin Co Ltd
AU2013293973B2 (en) * 2012-07-25 2017-04-06 Fujiyakuhin Co., Ltd. 4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridine-2-Carbonitrile Crystalline Polymorph and Production Method Therefor
CN103724329B (en) * 2013-12-23 2015-02-18 济南百诺医药科技开发有限公司 Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
CN104042577B (en) * 2014-06-13 2016-08-24 安徽省逸欣铭医药科技有限公司 A kind of stable Topiroxostat tablet and preparation method thereof
CN105315260A (en) * 2014-07-29 2016-02-10 北京海步医药科技股份有限公司 Topiroxostat monohydrate crystal form and preparation method thereof
CN105367490B (en) * 2014-08-18 2019-01-04 上海医药工业研究院 Synthesis support his new intermediate and preparation method thereof of pyrrole department
CN105348264B (en) * 2014-08-18 2018-01-16 上海医药工业研究院 A kind of his synthetic method of support pyrrole department
CN104151297B (en) * 2014-08-27 2016-03-16 王庆本 The preparation method of 4-[5-(pyridin-4-yl)-1H-[1,2,4] triazole-3-base] pyridine-2-formonitrile HCN
JP6684264B2 (en) * 2015-02-17 2020-04-22 株式会社三和化学研究所 Medicine for the prevention or treatment of heart failure
CN107427517B (en) 2015-02-24 2021-11-16 国立大学法人鸟取大学 Medicine for preventing and/or treating dementia
WO2016134854A1 (en) 2015-02-25 2016-09-01 Pharmathen S.A. Methods for the preparation of topiroxostat and intermediates thereof
CN105693699B (en) * 2015-03-30 2019-06-18 苏州晶云药物科技股份有限公司 Hold in the palm his crystal form and preparation method thereof of pyrrole department
CN104910068B (en) * 2015-04-24 2017-07-14 南京医科大学 A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5
CN106279111A (en) * 2015-05-12 2017-01-04 北京济美堂医药研究有限公司 His new method of a kind of refined torr pyrrole department
CN104961730B (en) * 2015-06-18 2017-05-17 山东金城医药化工股份有限公司 Novel topiroxostat crystal form and method for preparing same
CN105130958B (en) * 2015-08-31 2017-10-31 济南康和医药科技有限公司 The preparation technology of 5 (pyridine radicals of 2 cyano group 4) 3 (4 pyridine radicals) 1,2,4 triazoles
CN105294656A (en) * 2015-10-10 2016-02-03 大道隆达(北京)医药科技发展有限公司 Preparation process and method for topiroxostat
CN106336399A (en) * 2015-11-03 2017-01-18 江苏悦兴药业有限公司 Preparation method of Topiroxostat process impurity
CN105294584A (en) * 2015-11-30 2016-02-03 中国医科大学 1-substituted phenyl-1H-1,2,3-triazole compound as well as preparation method and application thereof
CN105399732A (en) * 2015-12-07 2016-03-16 青岛正大海尔制药有限公司 Preparation method of topiroxostat
CN106008465A (en) * 2016-03-16 2016-10-12 江苏悦兴药业有限公司 Topiroxostat impurity synthesis method
CN108250183A (en) * 2016-12-29 2018-07-06 北京诚济制药有限公司 A kind of preparation method of the Topiroxostat of high-purity
CN109721586B (en) * 2017-10-27 2021-03-02 中国医科大学 5-benzyl-3-pyridyl-1H-1, 2, 4-triazole compound and preparation method and application thereof
CN107652271B (en) * 2017-11-06 2020-06-16 上海中拓医药科技有限公司 Preparation method of topiroxostat crystal form I
CN108017619B (en) * 2017-12-06 2020-08-11 成都惟邦药业有限公司 Topiroxostat impurity and preparation method thereof
CN113354616B (en) * 2020-03-05 2024-03-26 中国医学科学院药物研究所 Diaryl-1, 2, 4-triazole compound and preparation method and pharmaceutical application thereof
CN113666909B (en) * 2020-05-14 2024-07-02 鲁南制药集团股份有限公司 Topiroxostat preparation method
CN114773262B (en) * 2022-05-19 2024-05-07 兄弟科技股份有限公司 Synthesis method of 2-cyano-4-pyridine carboxylic acid methyl ester

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112373A (en) * 1970-09-25 1972-03-28
US3963731A (en) * 1973-05-21 1976-06-15 Merck & Co., Inc. Pyridyl containing 1-benzenesulfonyl triazoles
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3882134A (en) * 1973-05-21 1975-05-06 Merck & Co Inc 1-Substituted-3,5-dipyridyl-1,2,4-triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
US3947577A (en) * 1973-05-21 1976-03-30 Merck & Co., Inc. Anti-hyperuricemia composition
US4104393A (en) * 1976-04-02 1978-08-01 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds
WO1993011433A1 (en) * 1991-12-05 1993-06-10 Wallac Oy Luminescent lanthanide chelates
US6413992B1 (en) * 1998-10-23 2002-07-02 Dow Agrosciences Llc 3-(substituted pyridyl)-1,2,4-triazole compounds
KR100838447B1 (en) * 2001-02-21 2008-06-16 아스트라제네카 아베 Heteropolycyclic Compounds and Their Use as Metabotropic Glutamate Receptor Antagonists

Similar Documents

Publication Publication Date Title
AU2002349754A1 (en) Novel 1,2,4-triazole compound
PL368672A1 (en) Novel 1,2,4-triazole compound
AU2002255263A1 (en) Novel 1H-indazole compound
AU2003266949A1 (en) Compounds
AU2003221098A1 (en) Oligofluorenylene compounds
AU2003279366A1 (en) Novel compounds
PL377187A1 (en) 1,3-dihydroimidazole fused-ring compound
AU2003211385A1 (en) Azole compounds
AU2003299648A1 (en) Substituted 4-phenyl-(1,3)-dioxanes
AU2002359165A1 (en) Novel compounds
AUPR362001A0 (en) New compound
AU2003274362A1 (en) Fungicides
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2003216859A1 (en) Amidoacetonitrile compounds
AU2003303955A1 (en) Sporicidal composition
AU2003288418A1 (en) Fungicides
AU2003274380A1 (en) Fungicides
AUPS044102A0 (en) New compound
AU2002951868A0 (en) Compound i
AU2003280948A1 (en) Fungicides
AU2003251259A1 (en) Novel compounds
AU2003292667A1 (en) Benzocycloheptapyridine compounds
AU2003275480A1 (en) Compounds
AU2003255322A1 (en) Compounds
AU2003208820A1 (en) Molluscicide